Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03927030

Ligand	Ligand name	Chain	PDB	Tanimoto
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.7
VD1	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RKG	0.72
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.73
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.73
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.73
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.7
VD5	(1R,3R,7E,17E)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4R	0.71
RCL	RICINOLEIC ACID	A	2CM4	0.7
RCL	RICINOLEIC ACID	A	2CM9	0.7
RCL	RICINOLEIC ACID	A	1FK7	0.7
3ON	(3R)-3-HYDROXY-8'-APOCAROTENOL	A,B,C,D	2BIW	0.72
FUA	FUSIDIC ACID	A	1QCA	0.74
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.74
FUA	FUSIDIC ACID	A,B	2VUF	0.74
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.71
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.73
0MA	maslinic acid	A	2QN2	0.74
0AS	asiatic acid	A	2QN1	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.72
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A	2GJ5	0.71
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A,B	3C6G	0.71
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.72
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.78
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.74
2OB	CHOLESTERYL OLEATE	A	2OBD	0.7
LUT	(3R,3'R,6S)-4,5-DIDEHYDRO-5,6-DIHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C,D,E,F,G,H,I,J	1RWT	0.75
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.71
EB1	SEOCALCITOL	A	1S0Z	0.73
D2V	(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol	A,B	3CZH	0.72
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.7
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.73
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.73
MC9	CALCIPOTRIOL	A	1S19	0.72
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.73
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.77
VD4	(1R,3R,7E,17Z)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4J	0.71
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.72
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.71
LUX	(3R,3'R,6'S,9R,9'R,13R,13'S)-4',5'-DIDEHYDRO-5',6',7',8',9,9',10,10',11,11',12,12',13,13',14,14',15,15'-OCTADECAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C	2BHW	0.74